Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (861-870 of 1,132) with videos related to

Pageof 114
Sort By:
Health Policy and Planning|June 4, 2019
Enhancing national prevention and treatment services for sex workers in Zimbabwe: a process evaluation of the SAPPH-IRe trialJoanna Busza, Tarisai Chiyaka, Sithembile Musemburi, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Plos One|March 5, 2013
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemicAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Nature|May 25, 2001
Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphereR Oren, D S Ellsworth, K H Johnsen, et al.
AIDS (London, England)|December 6, 2005
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markersCaroline A Sabin, Colette J Smith, Mike Youle, et al.
HIV Medicine|February 26, 2015
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA J Rodger, F C Lampe, A E Grulich, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
The Journal of Biological Chemistry|May 22, 2020
<i>Prochlorococcus</i> phage ferredoxin: structural characterization and electron transfer to cyanobacterial sulfite reductasesIan J Campbell, Jose Luis Olmos, Weijun Xu, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
The Journal of Infectious Diseases|September 20, 2005
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort studyColette J Smith, Andrew N Phillips, Teresa Hill, et al.
Pageof 114

Showing results (861-870 of 1,132) with videos related to

Sort By:
Pageof 114
Health Policy and Planning|June 4, 2019
Enhancing national prevention and treatment services for sex workers in Zimbabwe: a process evaluation of the SAPPH-IRe trialJoanna Busza, Tarisai Chiyaka, Sithembile Musemburi, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Plos One|March 5, 2013
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemicAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Nature|May 25, 2001
Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphereR Oren, D S Ellsworth, K H Johnsen, et al.
AIDS (London, England)|December 6, 2005
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markersCaroline A Sabin, Colette J Smith, Mike Youle, et al.
HIV Medicine|February 26, 2015
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA J Rodger, F C Lampe, A E Grulich, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
The Journal of Biological Chemistry|May 22, 2020
<i>Prochlorococcus</i> phage ferredoxin: structural characterization and electron transfer to cyanobacterial sulfite reductasesIan J Campbell, Jose Luis Olmos, Weijun Xu, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
The Journal of Infectious Diseases|September 20, 2005
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort studyColette J Smith, Andrew N Phillips, Teresa Hill, et al.
Pageof 114